Schedule 13G ownership disclosure
Forte Biosciences Inc
Common Stock · CUSIP: 34962G208
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Shares: 640,770 · Class: 9.99%
- TYBOURNE STRATEGIC OPPORTUNITIES GP II LIMITED
Shares: 640,770 · Class: 9.99%
- Tybourne Capital Management Ltd
Shares: 640,770 · Class: 9.99%
- Tybourne Kesari Ltd
Shares: 640,770 · Class: 9.99%
- Krishnan Viswanathan
Shares: 640,770 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-25-000794
- Form type
- SCHEDULE 13G/A
- Filer
- Forte Biosciences, Inc.
- CIK
- CIK 1419041
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership